...
机译:P2.03A-048 CDK4 / 6抑制剂G1T28在体内保护免疫细胞来自顺铂诱导的毒性,并抑制SCLC肿瘤?生长
Thoracic Head &
Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;
Thoracic Head &
Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;
Thoracic Head &
Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;
Thoracic Head &
Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;
Thoracic Head &
Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;
G1 Therapeutics;
G1 Therapeutics;
G1 Therapeutics;
G1 Therapeutics;
G1 Therapeutics;
Thoracic Head &
Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;
Thoracic Head &
Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;
机译:P2.03A-048 CDK4 / 6抑制剂G1T28在体内保护免疫细胞来自顺铂诱导的毒性,并抑制SCLC肿瘤?生长
机译:CDK4 / 6抑制抑制在临床前模型中提高化疗和免疫检查点抑制剂组合的抗肿瘤功效,增强了SCLC接受化疗的患者T细胞活化
机译:腺病毒介导的白细胞介素18突变体体内基因转移通过诱导T细胞免疫和激活自然杀伤细胞的细胞毒性来抑制肿瘤的生长
机译:纳米TiO2光动力学,免疫和电穿孔方法的组合技术,用于光杀死LoVo癌细胞并抑制LoVo肿瘤的生长
机译:荷电的NK细胞增加了肿瘤微环境中的免疫浸润,并抑制了人源化BLT小鼠的肿瘤生长。
机译:嵌合抗原受体T细胞在肿瘤基质中靶向成纤维细胞活化蛋白可以抑制肿瘤生长和增强宿主免疫力而无严重毒性
机译:CDK4 / 6抑制抑制在临床前模型中提高化疗和免疫检查点抑制剂组合的抗肿瘤功效,增强了SCLC接受化疗的患者T细胞活化